$0.87 $0.00 (0.3%)

04:00 PM EST on 11/18/19

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)

CAPS Rating: No stars

Current Price $0.87 Mkt Cap $53.5M
Open $0.87 P/E Ratio 0.00
Prev. Close $0.87 Div. (Yield) $0.00 (0.0%)
Daily Range $0.80 - $0.90 Volume 1,219,467
52-Wk Range $0.48 - $3.29 Avg. Daily Vol. 1,798,792

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

10 Outperform
1 Underperform
 

All-Star Players

1 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ADMP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jwburke (< 20)
Submitted April 14, 2015

ADMP is a specialty pharma focusing on low risk "quasi-generic" drugs in large target markets. They need to take very little market share to reap huge rewards to shareholders. ADMP has 4 inhaler Ph3 ready candidates and one allergy product already… More

zzlangerhans (99.79)
Submitted June 13, 2016

I got tuned into Adamis by Jake King, who runs the PropThink analytic service at propthink.com and can be found on Twitter at @FajaJake. If you're serious about biotech trading, he's a must-follow and you should consider investing in his service if… More

NASDAQ:ADMP VS S&P 500 (SPY)

NASDAQ:ADMP Summary

Fools bullish on NASDAQ:ADMP are also bullish on:

Fools bearish on NASDAQ:ADMP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ADMP.

Recs

0
Member Avatar TheIzzishWizzy (81.65) Submitted: 8/5/2016 3:27:24 PM : Outperform Start Price: $3.10 NASDAQ:ADMP Score: -122.73

more room to climb on approval

Recs

0
Member Avatar 2008Rehab (< 20) Submitted: 5/2/2015 12:50:22 PM : Outperform Start Price: $4.55 NASDAQ:ADMP Score: -128.60

These guys are repackaging a proven drug in a cheaper delivery system. Never mind if the FDA picks on them, eventually they will prevail.

Recs

1
Member Avatar jwburke (< 20) Submitted: 4/14/2015 9:00:16 AM : Outperform Start Price: $4.49 NASDAQ:ADMP Score: -130.16

ADMP is a specialty pharma focusing on low risk "quasi-generic" drugs in large target markets. They need to take very little market share to reap huge rewards to shareholders. ADMP has 4 inhaler Ph3 ready candidates and one allergy product already submitted to the FDA. Their largest potantial product is teh APC-5000 inhlaer they obtained from 3M and has been shown to be more effective than Advair in a recent PK study. They have backing by healthcare hedge fund Sio Capital and their very successful manager, Dr. Micahel Castor.

Leaderboard

Find the members with the highest scoring picks in ADMP.

Score Leader

shake656

shake656 (44.38) Score: +116.08

The Score Leader is the player with the highest score across all their picks in ADMP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
shake656 44.38 9/14/2016 Underperform 5Y $2.93 -70.30% +45.77% +116.08 0 Comment
TheIzzishWizzy 81.65 6/17/2016 Outperform 5Y $3.10 -71.93% +50.80% -122.73 1 Comment
tytwins13 31.30 5/18/2015 Outperform 5Y $4.21 -79.33% +47.02% -126.35 0 Comment
sonofadude < 20 8/7/2015 Outperform 5Y $3.76 -76.86% +50.07% -126.93 0 Comment
2008Rehab < 20 5/4/2015 Outperform 5Y $4.55 -80.88% +47.72% -128.60 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. jwburke < 20 4/14/2015 Outperform 3Y $4.49 -80.62% +49.54% -130.16 2 Comments
djs344 < 20 2/13/2015 Outperform 5Y $6.55 -86.72% +49.25% -135.96 2 Comments
bwalk037 20.23 4/1/2016 Outperform 3Y $6.17 -85.90% +51.64% -137.54 0 Comment
brooklyn053 39.80 8/24/2015 Outperform 5Y $3.50 -75.14% +64.64% -139.78 0 Comment
no1dreamer < 20 10/14/2014 Outperform 5Y $3.88 -77.57% +65.72% -143.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ADMP.